Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer

doi:10.4251/wjgo.v12.i11.1325

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5203)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

236

WORD

164

HTML

2282

Figures (1-3)

274

Tables (1-4)

225

Sum=3181

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

571

Download

1451

Sum=2022

Nov 15, 2020 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1325-1335
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1325

Full Size Figure Download Figure

Figure 3 Mean survival and 3-yr overall survival rates of different groups of 117 patients according to Cox multivariate analysis. TG: Total gastrectomy; STG: Subtotal gastrectomy; LNM: Lymph node metastasis; Chemo: Chemotherapy; MS: Median survival (mo); OSR: Overall survival rate.

Citation: Huang HB, Gao ZM, Sun AQ, Liang WT, Li K. Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer. World J Gastrointest Oncol 2020; 12(11): 1325-1335
URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1325.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1325